Evaxion Announces Expansion Of AI-Immunology Platform Into Autoimmune Diseases, Begins Experimental Testing Of Tolerogenic Vaccine And Autoantibody Binder Concepts; Initial Data Due At PEGS Europe November 18

Benzinga Newsdesk www.benzinga.com Neutral 57.6%

Neg 0% Neu 57.6% Pos 0%

Comments

No comments yet. Be the first!